Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Could Profit Be a Factor in Kidney Transplant Decisions?Get Up-to-the-Minute Safety Alerts Sent Straight to Your InboxPurdue Pharma to Settle Opioid Crisis Lawsuits, May Pay Up to $12 BillionWould a Health Warning on Every Cigarette Help Smokers Quit?Docs Prescribe More Opioids at Certain Time of DayFDA Warns Juul About Illegal Marketing Claims and Pitch to YouthComing Soon: A 'Pot Breathalyzer'?More CT, MRI Scans Being Used, Despite Calls to Cut BackCancer Overtakes Heart Disease as #1 Killer of Middle-Aged in Wealthy NationsOxyContin Maker Purdue Offering Up to $12 Billion to Settle Opioid ClaimsThousands of Kidneys Thrown Away by U.S. Transplant CentersJudge Orders Johnson & Johnson to Pay $572 Million Over Opioid Drug CrisisEvery Sudden Infant Death Deserves a Closer Look: ReportYour Chocolate Pot 'Edible' Could Hold a Hidden DangerCBD Is the Rage, But More Science Needed on Safety, EffectivenessMany Parents Would Switch Doctors Over Vaccination Policy, Poll FindsPot Poisonings Among Kids, Teens Double After Medical Marijuana Law PassedNearly Half of U.S. Patients Keep Vital Secrets From Their DoctorsFDA Proposes Graphic Warning Labels on CigarettesMany Doctors Refusing Care of People Prescribed OpioidsAll U.S. Adults Should Be Screened for Illicit Drug Use, National Panel UrgesAmericans' Trust in Scientists Follows a Sharp Political DivideRaising Legal Smoking Age to 21 WorksPure CBD Won't Make You Fail a Drug Test, But…Health Tip: Donate Blood SafelyRoutine Screening for Pancreatic Cancer Not Warranted, Expert Panel SaysResearchers 'Spin' Clinical Trial Findings in Top Psych Journals: StudyMore 'Buyer Beware' Warnings for Unregulated Stem Cell ClinicsSome of Most Common, Deadly Cancers Get the Least Research MoneyTraveling Abroad? Make Sure Your Measles Shot Is Up to DateHey! That's the Wrong Knee, DoctorBlood Donations Needed: Red CrossKeep Unused Meds Out of the Hands of AddictsFew U.S. Universities Are Smoke-FreeNeed Emergency Air Lift to Hospital? It Could Cost You $40,000California Took on Anti-Vaxxers, and WonAnti-Vaccine Movement a 'Man-Made' Health Crisis, Scientists WarnAHA News: Even the Threat of Homelessness May Bring Higher Stroke RiskFDA Warns Two Kratom Marketers About False ClaimsExperts Want Doctors to Add Vaping to Youth Prevention PitchMany Health Care Workers With Flu, Colds Still Go to Work: StudyGlobal Efforts to Cut Smoking Show Mixed ResultsOne Simple Food Substitution Might Help Save the PlanetAHA News: 3 Simple Steps Could Save 94 Million Lives WorldwideRace Affects Life Expectancy in Major U.S. CitiesDrugstores Often Don't Have Opioid Antidote in Stock, Philly Study ShowsAntibiotics Pollute Rivers Worldwide: StudyAHA News: For LGBTQ Patients, Discrimination Can Become Barrier to Medical CareImmigrants Make Up 1 in 4 U.S. Health Care WorkersFDA Takes Hard Look at CBD
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Routine Screening for Pancreatic Cancer Not Warranted, Expert Panel Says

HealthDay News
by -- Steven Reinberg
Updated: Aug 6th 2019

new article illustration

TUESDAY, Aug. 6, 2019 (HealthDay News) -- There's nothing to be gained by screening for pancreatic cancer in people with no signs or symptoms of the lethal tumor, according to an influential U.S. panel of experts.

Looking over the accumulated data on the subject, the U.S. Preventive Services Task Force (USPSTF) on Tuesday reaffirmed its prior recommendation against routine screening for pancreatic cancer.

The USPSTF is an independent, volunteer panel of national experts in prevention and evidence-based medicine.

"Pancreatic cancer is an uncommon, but devastating disease with low survival rates, even in those detected at early stages," task force member Dr. Chyke Doubeni, noted in a USPSTF statement.

However, "at the present time, screening for pancreatic cancer in people without any signs or symptoms would cause more harm than good and therefore should not be done," he added.

According to the USPSTF, there's no evidence that screening for pancreatic cancer improves patient outcomes. In addition, some screening tests are invasive and can be painful and possibly inaccurate. They can also damage the pancreas.

If cancer is found, surgery to remove the organ can result in significant bleeding, long recovery and possibly death, the task force also noted.

The trouble is that tumors of the pancreas are often discovered late, making the cancer a "silent killer." According to the American Cancer Society, about 57,000 Americans will be diagnosed with the disease in 2019, and almost 46,000 people will die from the illness.

Better screens are needed for early detection.

Task force member Dr. Chien-Wen Tseng said in the statement that "clinicians need to be able to find pancreatic cancer earlier in its development, when it is more treatable. The task force is calling for more research on effective and accurate screening tests that can detect pancreatic cancer earlier and that lead to fewer harms."

According to Dr. Sanjay Reddy, a cancer expert unconnected to the USPSTF, "The role of 'biomarkers,' or some sort of chemical blood test has the most promise in terms of early detection." Reddy is assistant professor of surgical oncology at Fox Chase Cancer Center in Philadelphia.

"However," he added, "to date, we still have no good way to test this -- the future of early detection remains our best option for screening not only high-risk patients, but all patients."

The panel stressed that screening for pancreatic cancer may still be warranted for people deemed to be at high risk for the disease.

More information

For more on pancreatic cancer, head to the American Cancer Society.




Facebook

Amazon Smile

To quit smoking, call Connecticut QuitLine at 1-800-QUIT-NOW.

Children and Adult services are available now with no wait time.  Please contact HBH Intake Department at 860-548-0101, option 2.

 


powered by centersite dot net